324 filings
Page 3 of 17
8-K
uxl4qkocqkxh4g
15 Feb 23
Skye Bioscience Closes Sale of Subsidiary, Verdélite Sciences, to C3 Souvenir Holding, with USD$5.60M Closing Payment
4:26pm
8-K
bcv v2joc9x3
26 Jan 23
Entry into a Material Definitive Agreement
9:22pm
8-K
ct5oa44d1w3rkadj6sd
6 Jan 23
Entry into a Material Definitive Agreement
4:57pm
8-K
ff4492olpwb 8v
16 Dec 22
Entry into a Material Definitive Agreement
6:40pm
8-K
pl4cn k37wyv6thko6
23 Nov 22
Entry into a Material Definitive Agreement
5:23pm
8-K
rxy2b
18 Oct 22
Entry into a Material Definitive Agreement
5:44pm
8-K
ezee4p49zrdfsms28o
3 Oct 22
Changes in Registrant's Certifying Accountant
5:14pm
DEFA14A
ebbgv
1 Sep 22
Additional proxy soliciting materials
4:00pm
DEFM14A
2equto
31 Aug 22
Proxy related to merger
5:19pm
PREM14A
u9za zryp
15 Aug 22
Preliminary proxy related to merger
12:00am
8-K
me3t55mibhi
20 Jul 22
Entry into a Material Definitive Agreement
7:01pm
8-K
rt648y
17 Jun 22
Entry into a Material Definitive Agreement
5:22pm
8-K
iykwl8x8a
23 May 22
Entry into a Material Definitive Agreement
5:05pm
8-K
w48a962z
12 May 22
Skye Bioscience Signs Arrangement Agreement with Emerald Health Therapeutics
9:08am
8-K
8whzs00t
20 Dec 21
Skye Bioscience Announces Promotion of Tu Diep, MSc to Chief Development Officer
5:25pm
424B3
b48kysu
10 Nov 21
Prospectus supplement
8:57am